Sleep apnea

If sleep got worse around 45, you snore now and didn't used to, you wake unrefreshed no matter how many hours you logged, or your partner has noticed you stop breathing — please don't write it off as 'just perimenopause.' Women's sleep apnea triples after the menopause transition, presents differently from men's, and is one of the most consistently missed diagnoses in midlife medicine.

Sleep apnea triples in women after the menopause transition. Three intersecting mechanisms — and a diagnostic system mostly designed around how it shows up in men.

Estrogen and progesterone keep the upper airway open at night. Progesterone is a respiratory stimulant; it tones the upper airway dilator muscles and drives ventilation. Estrogen modulates fat distribution and inflammation around the airway. When both fall, the airway becomes more collapsible during sleep — especially in REM. This is mechanism, not bad luck.

Prevalence in women rises sharply at menopause. Pre-menopause, the female:male OSA ratio is roughly 1:3. Post-menopause, it narrows to about 1:1. Untreated severe OSA at least triples cardiovascular and stroke risk and is independently linked to atrial fibrillation, hypertension, type 2 diabetes and accelerated cognitive decline. This isn't a snoring nuisance.

Women's OSA presents differently — and gets missed. The textbook OSA picture — loud snoring, witnessed apnoeas, daytime sleepiness in a heavier middle-aged man — fits people badly. People more often present with insomnia, anxiety, morning headaches, depression, fatigue, brain fog, and unrefreshing sleep, with quieter snoring or none. The standard Epworth Sleepiness Scale under-detects female OSA by design.

It can happen at any weight. About a third of people with OSA have a BMI under 25. Anatomical features — small recessed jaw, narrow palate, large tongue, thick neck relative to frame — matter as much as weight. 'You're not the apnea type' is a doctor's failure of pattern recognition, not a diagnostic statement.

It's often what's actually broken — not 'menopause insomnia'. Many people medicate perimenopausal sleep problems with hypnotics, magnesium, melatonin and MHT for a year before anyone asks the apnea question. If sleep doesn't improve on MHT and basic sleep hygiene, OSA is the next thing to rule out — not the last.

OSA isn't a self-treat condition. The work is getting an accurate diagnosis (a sleep study), then matching treatment to severity. Everything else — weight, alcohol, position — is supporting cast.

Ask for a sleep study by name — don't accept 'try a sleep tracker'. The diagnostic gold standard is a sleep study (polysomnography in a lab, or a validated home sleep apnea test — HSAT — for typical adult OSA). Consumer wearables (Apple Watch, Oura, Whoop) detect patterns suggestive of OSA but don't diagnose it. If you're waving an Apple Watch screenshot at your GP, you're asking for the right test, not getting the diagnosis itself.

Use a female-specific screening tool. The STOP-BANG questionnaire was validated mostly on men and under-detects women. Ask your doctor to consider the female-specific symptom cluster (insomnia, fatigue, morning headache, depression, unrefreshing sleep) and not just snoring + observed apnoeas. Print the female-pattern criteria if you have to — your GP may not have seen it.

CPAP is the most effective treatment we have. Continuous positive airway pressure is the first-line treatment for moderate-to-severe OSA. Modern machines are quiet, the masks are vastly better than a decade ago, and the difference in how a treated person feels by week 4–8 is often transformative. The adherence problem is mostly a mask-fit problem; persist through three masks before giving up.

Mandibular advancement devices for mild–moderate OSA. A custom dental appliance (made by a sleep-trained dentist, NOT a boil-and-bite from a pharmacy) holds the jaw forward overnight. Less effective than CPAP for severe disease, but well-tolerated and a reasonable first step for mild–moderate OSA, especially when CPAP has been tried and rejected.

Positional therapy if events are mostly supine. A non-trivial subset have OSA almost only when sleeping on their back. A simple positional device (or a t-shirt with a tennis ball sewn in) can be remarkably effective for selected people. The sleep study will tell you whether this is your pattern.

Treat the alcohol and the hypnotics. Alcohol and benzodiazepines/'z-drugs' (zopiclone, zolpidem) both relax upper airway muscles and lengthen events. If you suspect or have OSA, alcohol within 3 hours of bed is meaningfully more harmful than for the general population, and hypnotic sleeping pills should be reviewed with your doctor, not added.

MHT may help, but isn't a substitute for treating apnea. Some evidence that MHT (particularly with micronised progesterone, given its respiratory stimulant effects) modestly improves OSA severity in postmenopausal people. It isn't a stand-alone treatment for moderate-to-severe OSA. Treat the apnea first; MHT alongside for the broader picture.

Modest weight loss helps where weight is a factor. A 5–10% weight reduction can meaningfully reduce OSA severity in those for whom weight is contributing. It isn't a moral story and it isn't the answer for the lean third of female OSA cases. Don't let weight advice delay the sleep study.

Treat nasal congestion seriously. Chronic nasal obstruction (allergies, deviated septum, perimenopausal nasal dryness) increases OSA severity and undermines CPAP comfort. Saline rinses, treated allergies and — where indicated — an ENT review can quietly halve the apnea problem.

Myofunctional therapy for mild cases. Tongue and oropharyngeal exercise programmes (delivered by a trained myofunctional therapist or speech-language pathologist) have small but real effects on mild OSA and snoring. Useful adjunct, not a primary treatment.